A global conference in San Diego brings together thousands of cancer researchers, physician-scientists, patient advocates, policymakers, and others to accelerate progress against cancer.
Pioneering chemist and Fellow of the AACR Academy Carolyn R. Bertozzi, PhD, leads efforts to develop cancer therapeutics against “a different type of drug target.”
Learn MoreAACR grantee Raymond E. Moellering, PhD, of the University of Chicago uses chemistry to build “molecules that can go after “undruggable” protein targets to treat cancers.
Learn MorePioneering researchers and physician-scientists elected as Fellows of the AACR Academy in 2024.
Learn MoreChemtai Mungo is researching an innovative self-treatment strategy for cervical precancer could save lives of women in underserved areas.